[Evaluation by metabolic markers of bone].
Metabolic markers of bone are useful for the evaluation of future bone mineral loss and risk of fractures. Recent studies suggest the markers are one of indicators of suppression of turnover by anti-resorptive treatment. Although only urinary markers are reimbursed and numbers of measurement are limited by health insurance, Japanese standard values, and minimum significant changes were already published. Effectiveness of the treatment by bisphosphonate and HRT can be evaluated by the measurement of the markers individually. The compliance of the treatment can be improved by the information of the changes of markers by treatment. Utilization of serum markers may change the selection of treatment modalities.